Patent details

Basic Information

Publication number:

EP2389586

PCT Application Number:

US2009031678

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097894356

PCT Publication Number:

WO2010085251

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GALACTOSE-ALPHA-1,3-GALACTOSE-CONTAINING N-GLYCANS IN GLYCOPROTEIN PRODUCTS DERIVED FROM CHO CELLS

French Title of Invention:

N-GLYCANES CONTENANT DU GALACTOSE-ALPHA-1,3-GALACTOSE DANS DES PRODUITS DE TYPE GLYCOPROTÉINES DÉRIVÉS DE CELLULES CHO

German Title of Invention:

GALACTOSE-ALPHA-1, 3-GALACTOSE ENTHALTENDE N-GLYKANE IN AUS CHO-ZELLEN GEWONNENEN GLYKOPROTEINPRODUKTEN

SPC Number:

Dates

Filing date:

22/01/2009

Grant date:

25/06/2014

EP Publication Date:

30/11/2011

PCT Publication Date:

29/07/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/11/2011

EP B1 Publication Date:

25/06/2014

EP B2 Publication Date:

24/01/2018

EP B3 Publication Date:

Lapsed date:

22/01/2015

Expiration date:

22/01/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/01/2018

 

 

Name:

Momenta Pharmaceuticals, Inc.

Address:

675 West Kendall Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

MURPHY, Jennifer

Address:

United States (US)

2

Name:

XU, Xiao-Jin

Address:

United States (US)

3

Name:

WASHBURN, Nathaniel

Address:

United States (US)

4

Name:

LIU, Cuihua

Address:

United States (US)

5

Name:

BOSQUES, Carlos

Address:

United States (US)

6

Name:

SARVAIYA, Hetal

Address:

United States (US)

Classification

IPC classification:

G01N 33/68;

Publication

European Patent Bulletin

Issue number:

201804

Publication date:

24/01/2018

Description:

Patent maintained (B2 publication)

Filing date	Document type	Number of pages